West Lafayette-based Kylin Therapeutics Inc. has hired Henry Li as director of its research and development
team. He was director of research and pharmacology at San Diego-based NexBio Inc., which develops drugs to treat pandemic
influenza.
Please enable JavaScript to view this content.